Want to know how contentious drug pricing is in Washington? Check the receipts
PhRMA’s 34 member companies dropped more than $120 million lobbying Congress in 2019 — a sum that helped pay for more than 450 lobbyists.
WASHINGTON — Pfizer, Johnson & Johnson, Merck, and the 31 other major drug makers that belong to the trade group PhRMA together spent more than $120 million lobbying Congress in 2019, according to recently released federal disclosures.
That helped pay for an army of over 450 lobbyists who helped the drug makers and their trade group vehemently oppose the sweeping proposals lawmakers and the Trump administration put forth in their efforts to lower prescription drug prices.
PhRMA also broke its all-time annual lobbying record this year. It spent $28.9
